Clinical Trial Update: Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for CMR316 evaluating safety and pharmacology in healthy volunteers and patients with idiopathic pulmonary fibrosis, currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• CMR316

Snippet

Sponsor: Calibr, a division of Scripps Research | Conditions: Pulmonary Fibroses, Idiopathic | Phase 1 | Status: RECRUITING